by Market Overview:
Cell surface markers detection tests are widely used for various medical applications such as immune-phenotyping for disease diagnosis and monitoring, stem cell research and toxicity assessment. These tests help in identification of specific cell surface markers expressed on white blood cells, stem cells and cancer cells to analyze cell types, cell differentiation and immune cell functions. The tests are carried out using various techniques such as flow cytometry, immunohistochemistry and immunofluorescence. The easy availability and accuracy of cell surface markers detection tests have increased their demand across diagnostic and research laboratories globally.
Market Key Trends:
One of the key trends in the cell surface markers detection market is increasing adoption of automated and high-throughput flow cytometry systems. Traditional flow cytometry requires manual preparation of cells and reagents which makes the process time-consuming and prone to errors. However, various players are now developing automated flow cytometry platforms integrated with sophisticated detection hardware and software for high-speed, accurate cell surface marker analysis.
This increases efficiency and throughput of cell-based assays in research and clinical settings. Another major trend is rising focus on stem cell and cancer immunotherapy. Cell surface markers play a vital role in stem cell differentiation and immune cell target identification. Players are developing novel markers and highly sensitive assays to advance regenerative medicine and cancer immunotherapies. This will propel the demand for advanced cell surface markers detection solutions in the coming years.
Porter’s Analysis
Threat of new entrants: The cell surface markers detection market requires high R&D investment and regulatory compliances which increases the entry barriers for new players.
Bargaining power of buyers: The market has large number of established players supplying varied products. However, high capital requirement reduces the bargaining power of buyers.
Bargaining power of suppliers: The key raw materials required are available with multiple suppliers globally which reduces their bargaining power.
Threat of new substitutes: There are limited substitutes available for cell surface markers detection technology due to its high specificity and sensitivity.
Competitive rivalry: The market players differentiate their products through technological advancements leading to stiff competition.
Key Takeaways
The Global Cell Surface Markers Detection Market Demand is expected to witness high growth, exhibiting CAGR of 9.1% over the forecast period, due to increasing R&D activities and rising demand for cancer diagnostics.
Regional analysis: North America is expected to dominate the global cell surface markers detection market during the forecast period owing to huge cancer burden, developed healthcare infrastructure and increasing funding for life science research in the region. Asia Pacific exhibits the fastest growth due to rising healthcare expenditure, increasing disposable income, growing elderly population and improving healthcare facilities.
Key players operating in the cell surface markers detection market are Grifols SA, Abbott Laboratories, Sysmex Corporation, Agilent Technologies Inc., Nexcelom Bioscience, Thermo Fisher Scientific Inc., Siemens Healthineers, Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd., Bio Rad Laboratories Inc., Becton, Dickinson and Company (BD), Qiagen NV, Diasorin SpA (Luminex Corporation), Danaher Corporation (Beckman Coulter Inc.), and IVD Medical Holding Limited (Immucor Inc.), among others.
Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
